title: Complete regression of a suprasellar secondary mass in a patient with low-grade non-Hodgkin's lymphoma (NHL) treated with 2-chlorodeoxyadenosine (CdA)
authors.forename: F
authors.initials: F
authors.lastname: deCataldo
authors.forename: F
authors.initials: F
authors.lastname: Baudo
authors.forename: C
authors.initials: C
authors.lastname: Ottonelli
authors.forename: C
authors.initials: C
authors.lastname: Italia
authors.forename: R
authors.initials: R
authors.lastname: Valdagni
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000556:secondary; D002423:Cause of Death; D017338:Cladribine / Q000627:therapeutic use*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000000981:diagnostic imaging / Q000188:drug therapy*; D008875:Middle Aged; D012074:Remission Induction; D014057:Tomography, X-Ray Computed
chemical_list: D000970:Antineoplastic Agents; D017338:Cladribine